Neuro-stimulation device gets €26 million in equity finance

A neuro-stimulation device developed by G-Therapeutics BV of the Netherlands has received €26 million in Series A equity finance to fund a clinical trial in patients with spinal cord injuries ahead of a regulatory submission.